2012: Year in review
Recent articles
What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?

What stood out to you in 2012?
We packaged the year’s research highlights from our vantage point. What advances stood out to you in 2012? And where do you see the field going?
Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.

Top tools and techniques of 2012
2012 saw many new exciting — and often colorful — technical advances, ranging from tools that build brains from the cell up to robots that can replace neuroscientists.
Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.

Drugs in development for autism
A look at various drugs attempting to address autism and their stages of development.

Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.

Predictions for 2013
Take a look through SFARI.org’s crystal ball to predict major developments in autism research in 2013.
Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.

Most-viewed articles of 2012
A list of the ten stories that most caught our readers’ attention this year.
Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.

Hot topics in 2012
New candidate genes, drugs in development and diagnostic debates were just a few of the themes that garnered intense interest this year.
Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.

Director’s column: 2012 in review
SFARI director Gerald Fischbach comments on the year’s most notable papers.
Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.

Notable papers of 2012
Among a wealth of exciting research, ten sets of papers made an impact this year.
Explore more from The Transmitter
Sounding the alarm on pseudoreplication: Q&A with Constantinos Eleftheriou and Peter Kind
Most studies of neurological disorders in mice erroneously treat multiple samples from a single animal as independent replicates, according to a new analysis. But scientists and journals can take steps to curb this practice.

Sounding the alarm on pseudoreplication: Q&A with Constantinos Eleftheriou and Peter Kind
Most studies of neurological disorders in mice erroneously treat multiple samples from a single animal as independent replicates, according to a new analysis. But scientists and journals can take steps to curb this practice.
Psychedelics meta-analysis retracted after authors request ‘significant changes’
While working on a similar analysis last year, an independent researcher spotted inconsistencies in the now-retracted paper.

Psychedelics meta-analysis retracted after authors request ‘significant changes’
While working on a similar analysis last year, an independent researcher spotted inconsistencies in the now-retracted paper.
Some dopamine neurons signal default behaviors to reinforce habits
Movement-sensing neurons that target the striatum influence a mouse’s choice of action by favoring routine.

Some dopamine neurons signal default behaviors to reinforce habits
Movement-sensing neurons that target the striatum influence a mouse’s choice of action by favoring routine.